Page last updated: 2024-09-05

phosphatidylcholines and thromboxane b3

phosphatidylcholines has been researched along with thromboxane b3 in 1 studies

Compound Research Comparison

Studies (phosphatidylcholines)	Trials (phosphatidylcholines)	Recent Studies (post-2010) (phosphatidylcholines)	Studies (thromboxane b3)	Trials (thromboxane b3)	Recent Studies (post-2010) (thromboxane b3)
32,204	443	5,593	14	4	4

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bottsford-Miller, JN; Dial, EJ; Dorniak, PL; Fang, D; Filant, J; Haemmerle, M; Hansen, JM; Hatakeyama, H; Hu, W; Huang, Y; Lichtenberger, LM; Lyons, Y; Pradeep, S; Previs, RA; Shen, F; Sood, AK; Taylor, M; Wagner, MJ	1

Other Studies

1 other study(ies) available for phosphatidylcholines and thromboxane b3

Article	Year
Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer. Molecular cancer therapeutics, 2016, Volume: 15, Issue:12 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Aspirin; Biomarkers; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Hypoxia; Mice; Neovascularization, Pathologic; Ovarian Neoplasms; Phosphatidylcholines; Thromboxanes; Xenograft Model Antitumor Assays	2016

Article

Year

Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer.

Molecular cancer therapeutics, 2016, Volume: 15, Issue:12

Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Aspirin; Biomarkers; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Hypoxia; Mice; Neovascularization, Pathologic; Ovarian Neoplasms; Phosphatidylcholines; Thromboxanes; Xenograft Model Antitumor Assays

2016